Showing results (1831-1840 of 2,748) with videos related to

Sort By:
Pageof 275
Clinical and Experimental Nephrology|November 27, 2012
The mitochondrial protein frataxin is downregulated in hemodialysis patientsYukiko Hasuike, Takanori Nagai, Soshi Yorifuji, et al.
Clinical and Experimental Nephrology|November 28, 2012
The relationship of plasma ADMA levels with cardiac functions and metabolic parameters in peritoneal dialysis patientsSavas Ozturk, Serhat Karadag, Metin Yegen, et al.
Clinical and Experimental Nephrology|November 30, 2012
Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo studyHiroyuki Terawaki, Masaaki Nakayama, Emiko Miyazawa, et al.
Clinical and Experimental Nephrology|October 17, 2013
Dynamic regulation and dysregulation of the water channel aquaporin-2: a common cause of and promising therapeutic target for water balance disordersYumi Noda
Clinical and Experimental Nephrology|November 28, 2013
Comparison of kidney disease: improving global outcomes and acute kidney injury network criteria for assessing patients in intensive care unitsHibiki Shinjo, Waichi Sato, Enyu Imai, et al.
Clinical and Experimental Nephrology|December 10, 2013
Effects of three kinds of erythropoiesis-stimulating agents on renal anemia in Japanese non-dialysis chronic kidney disease patientsMichio Kuwahara, Syoko Hasumi, Shintaro Mandai, et al.
Clinical and Experimental Nephrology|November 13, 2013
Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetesAndrzej S Krolewski, Tomohito Gohda, Monika A Niewczas
Clinical and Experimental Nephrology|November 7, 2014
High renal resistive index in hypertensive patients is also associated with serum homocysteine levelŞakir Özgür Keşkek, Yavuz Çinar, Sinan Kirim, et al.
Clinical and Experimental Nephrology|October 30, 2014
Contrast-enhanced ultrasound (CEUS) in nephrology: Has the time come for its widespread use?Antonio Granata, Luca Zanoli, Monica Insalaco, et al.
Clinical and Experimental Nephrology|October 30, 2014
Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in JapanEiji Higashihara, Kikuo Nutahara, Takatsugu Okegawa, et al.
Pageof 275